Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin-resistance and lipoprotein abnormalities.

J C Fruchart1

  • 1Serlia et U. INSERM 325, Institut Pasteur, Lille, France.

Diabete & Metabolisme
|May 1, 1991
PubMed
Summary

Insulin resistance is linked to higher triglyceride levels and lower HDL cholesterol. Analyzing specific lipoprotein particle profiles, especially those with apo B and apo A-I, is crucial for understanding cardiovascular disease risk and diabetes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis.

Metabolism: clinical and experimental·2001
Same author

Overview. PPAR and cardiovascular risk.

Journal of cardiovascular risk·2001
Same author

PPARS in inflammation, atherosclerosis and thrombosis.

Journal of cardiovascular risk·2001
Same author

[New concepts on the mechanism of action of fibrates and therapeutic prospectives in atherosclerosis].

Bulletin de l'Academie nationale de medecine·2001
Same author

Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2001
Same author

Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta.

The Journal of biological chemistry·2001

Area of Science:

  • Lipid metabolism and cardiovascular disease research
  • Biochemistry of lipoproteins and apolipoproteins
  • Endocrinology and metabolic disorders

Background:

  • Insulin resistance is associated with increased VLDL-triglyceride synthesis and secretion, potentially leading to hypertriglyceridemia.
  • Individuals with insulin resistance often exhibit lower HDL cholesterol levels.
  • Lipoproteins (VLDL, IDL, LDL, HDL) are heterogeneous, with distinct apolipoprotein compositions influencing their metabolism.

Purpose of the Study:

  • To investigate the diagnostic value of measuring apolipoprotein B (apo B) and apolipoprotein A-I (apo A-I).
  • To clarify the role of specific lipoprotein particle profiles in metabolic disorders and atherosclerosis.
  • To differentiate the functions of HDL subpopulations based on apolipoprotein content.

Main Methods:

  • Utilized enzyme-linked differential antibody immunosorbent assay and differential electroimmunoassay.
  • Determined lipoprotein particle profiles based on apolipoprotein composition.
  • Analyzed the association between insulin resistance, glucose disposal rates, and lipoprotein levels.

Main Results:

  • Lipoprotein particle profiling is essential for clarifying the diagnostic value of apo B and apo A-I measurements.
  • Specific apo B-containing lipoprotein subpopulations (LpB, LpB:E) are identified as atherosclerosis risk factors.
  • HDL's protective effect is attributed to apo A-I containing particles (LpA-I), not those with apo A-I and apo A-II (LpA-I:A-II).
  • Non-insulin-dependent diabetic patients (NIDDM) show increased levels of cholesteryl ester-rich LpB and triglyceride-rich LpB:C-III and LpB:E.

Conclusions:

  • Lipoprotein particle composition significantly impacts the metabolism of apo B and apo A-I containing particles.
  • Understanding lipoprotein subpopulations provides deeper insights into cardiovascular risk and metabolic disease.
  • Targeting specific lipoprotein particles may offer new diagnostic and therapeutic strategies for NIDDM and atherosclerosis.

Related Experiment Videos